Insider · CIK 0001315306
Hideki Nagao
Files at MNOV (MEDICINOVA INC). First filing -, latest -.
In brief
Hideki Nagao files SEC Form 4 as director at MNOV (MEDICINOVA INC). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Hideki Nagao has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 2 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jun 23, 2026 | MNOV MEDICINOVA INC | AGrant or award Stock Option (Right to Buy)derivative | +44,500 | $0.00 | $0 | 44,500 | Jun 25, 2026 |
| Jun 17, 2025 | MNOV MEDICINOVA INC | AGrant or award Stock Option (Right to Buy)derivative | +20,000 | $0.00 | $0 | 20,000 | Jun 20, 2025 |
Questions about Hideki Nagao
Answered from the filings on this page, as of the latest one.
Is Hideki Nagao buying or selling?
Hideki Nagao has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Hideki Nagao's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Hideki Nagao has 0.
Where does Hideki Nagao file Form 4?
Hideki Nagao has filed Form 4 at MNOV (MEDICINOVA INC). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.